MAPT and Alzheimer disease: Moreover, tyrosine kinases, including members of the SRC and ABL families, target specific amino acid residues associated with tau aggregation and Alzheimer’s disease, further illustrating complexity of the regulation for this amino acid post-translational modification [76,77].